BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 34958880)

  • 1. The Montreal Cognitive Assessment is a valid cognitive screening tool for cardiac arrest survivors.
    van Gils P; van Heugten C; Hofmeijer J; Keijzer H; Nutma S; Duits A
    Resuscitation; 2022 Mar; 172():130-136. PubMed ID: 34958880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in SLE.
    Raghunath S; Glikmann-Johnston Y; Morand E; Stout JC; Hoi A
    Lupus Sci Med; 2021 Dec; 8(1):. PubMed ID: 34911821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for cognitive impairment with the Montreal Cognitive Assessment in Chinese patients with acute mild stroke and transient ischaemic attack: a validation study.
    Zuo L; Dong Y; Zhu R; Jin Z; Li Z; Wang Y; Zhao X; Sachdev P; Zhang W; Wang Y
    BMJ Open; 2016 Jul; 6(7):e011310. PubMed ID: 27406642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for cognitive impairment in older adults with hematological malignancies using the Montreal Cognitive Assessment and neuropsychological testing.
    Koll TT; Sheese AN; Semin J; Ernst W; High R; Wildes TM; Fisher A; Murman DL
    J Geriatr Oncol; 2020 Mar; 11(2):297-303. PubMed ID: 31831362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Montreal Cognitive Assessment (MoCA) - a sensitive screening instrument for detecting cognitive impairment in chronic hemodialysis patients.
    Tiffin-Richards FE; Costa AS; Holschbach B; Frank RD; Vassiliadou A; Krüger T; Kuckuck K; Gross T; Eitner F; Floege J; Schulz JB; Reetz K
    PLoS One; 2014; 9(10):e106700. PubMed ID: 25347578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of three cognitive exams in cardiac arrest survivors.
    Koller AC; Rittenberger JC; Repine MJ; Morgan PW; Kristan J; Callaway CW;
    Resuscitation; 2017 Jul; 116():98-104. PubMed ID: 28511984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Validation of the Montreal Cognitive Assessment (MoCA) as a screening tool for mild cognitive impairment in the population of Buenos Aires, Argentina].
    González Palau F; Berrios W; García Basalo MM; Ojea Quintana M; Fernández M; García Basalo MJ; Fernández MC; Cámpora N; Matusevich LD; Golimstok Á
    Vertex; 2018 Jul; XXIX(140):261-269. PubMed ID: 30778419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The validation of the Beijing version of the Montreal Cognitive Assessment in Chinese patients undergoing hemodialysis.
    Tian R; Guo Y; Ye P; Zhang C; Luo Y
    PLoS One; 2020; 15(1):e0227073. PubMed ID: 31917792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Responsiveness to Change of the Montreal Cognitive Assessment, Mini-Mental State Examination, and SCOPA-Cog in Non-Demented Patients with Parkinson's Disease.
    Faust-Socher A; Duff-Canning S; Grabovsky A; Armstrong MJ; Rothberg B; Eslinger PJ; Meaney CA; Schneider RB; Tang-Wai DF; Fox SH; Zadikoff C; Kennedy N; Chou KL; Persad C; Litvan I; Mast BT; Gerstenecker AT; Weintraub S; Reginold W; Marras C
    Dement Geriatr Cogn Disord; 2019; 47(4-6):187-197. PubMed ID: 31315127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity of the Montreal Cognitive Assessment in screening for cognitive impairment in patients with newly diagnosed high-grade glioma.
    Ribeiro M; Durand T; Roussel M; Feuvret L; Jacob J; Psimaras D; Noel G; Keller A; Bompaire F; Hoang-Xuan K; Bernier MO; Godefroy O; Ricard D
    J Neurooncol; 2020 Jun; 148(2):335-342. PubMed ID: 32415644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity of the Montreal Cognitive Assessment Screener in Adolescents and Young Adults With and Without Congenital Heart Disease.
    Pike NA; Poulsen MK; Woo MA
    Nurs Res; 2017; 66(3):222-230. PubMed ID: 28448372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for cognitive impairment in systemic lupus erythematosus: Application of the Montreal Cognitive Assessment (MoCA) in a Greek patient sample.
    Papastefanakis E; Dimitraki G; Ktistaki G; Fanouriakis A; Karamaouna P; Bardos A; Kallitsakis I; Adamichou C; Gergianaki I; Repa A; Bertsias G; Sidiropoulos P; Karademas E; Simos P
    Lupus; 2021 Dec; 30(14):2237-2247. PubMed ID: 34861804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the Spanish-language version of the Montreal Cognitive Assessment as a screening test for cognitive impairment in multiple sclerosis.
    Gomez-Moreno SM; Cuadrado ML; Cruz-Orduña I; Martínez-Acebes EM; Gordo-Mañas R; Fernández-Pérez C; García-Ramos R
    Neurologia (Engl Ed); 2022; 37(9):726-734. PubMed ID: 34836843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The validity of the Montreal cognitive assessment (MoCA) for the screening of vascular cognitive impairment after ischemic stroke.
    Potocnik J; Ovcar Stante K; Rakusa M
    Acta Neurol Belg; 2020 Jun; 120(3):681-685. PubMed ID: 32193731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the Quick Mild Cognitive Impairment (Qmci) screen to the Montreal Cognitive Assessment (MoCA) in an Australian geriatrics clinic.
    Clarnette R; O'Caoimh R; Antony DN; Svendrovski A; Molloy DW
    Int J Geriatr Psychiatry; 2017 Jun; 32(6):643-649. PubMed ID: 27427212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the Turkish Version of the Montreal Cognitive Assessment Scale (MoCA-TR) in patients with Parkinson's disease.
    Ozdilek B; Kenangil G
    Clin Neuropsychol; 2014; 28(2):333-43. PubMed ID: 24528299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of the Montreal Cognitive Assessment (MoCA) screening tool to evaluate cognitive deficits in Lebanese in-patients with schizophrenia.
    Haddad C; Salameh P; Sacre H; Clément JP; Calvet B
    Asian J Psychiatr; 2022 Apr; 70():103029. PubMed ID: 35189473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation in French of the Montreal Cognitive Assessment 5-Minute, a brief cognitive screening test for phone administration.
    Dujardin K; Duhem S; Guerouaou N; Djelad S; Drumez E; Duhamel A; Bombois S; Nasreddine Z; Bordet R; Deplanque D
    Rev Neurol (Paris); 2021 Oct; 177(8):972-979. PubMed ID: 33478740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Montreal Cognitive Assessment (MoCA) as a screening test for cognitive dysfunction in multiple sclerosis.
    Freitas S; Batista S; Afonso AC; Simões MR; de Sousa L; Cunha L; Santana I
    Appl Neuropsychol Adult; 2018; 25(1):57-70. PubMed ID: 27791389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cog-4 has limited diagnostic test accuracy and validity for cognitive assessment in stroke survivors.
    Lees R; Lua J; Melling E; Miao Y; Tan J; Quinn TJ
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1604-10. PubMed ID: 24674952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.